BamSEC and AlphaSense Join Forces
Learn More

Cardiff Oncology Inc.

NASDAQ: CRDF    
Share price (12/20/24): $4.26    
Market cap (12/20/24): $218 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Cardiff Oncology, Inc. Certificate of Elimination of Series B, Series C, Series D and Series E Convertible Preferred Stock Pursuant to Section 151(g) of the General Corporation Law of the State Of
12/34/56
EX-3.1
from 8-K 19 pages Cardiff Oncology, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 5 pages Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Amended and Restated Certificate of Incorporation of Trovagene, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment No. 2 to the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of the Amended and Restated Certificate of Incorporation Under Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from DEFA14A 1 page Amendment No. 1 to the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Amendment No. 1 to the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 5 pages Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law 1
12/34/56
EX-3.1
from 8-K 17 pages Trovagene, Inc. State of Delaware Secretary of State Division of Corporations Delivered 01:11 Pm 06/08/2018 Filed 01:11 Pm 06/08/2018 Sr 20185050514 – File Number 4733134 Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.6
from S-1/A 16 pages Trovagene, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Series B Preferred Stock
12/34/56
EX-3.5
from S-1/A 19 pages Trovagene, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware 1 Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of the Amended and Restated Certificate of Incorporation Under Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Trovagene, Inc. Under Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 10-12G 13 pages By-Laws of Trovagene, Inc
12/34/56
EX-3.1
from 10-12G 4 pages Amended and Restated Certificate of Incorporation of Trovagene, Inc
12/34/56
EX-3.1
from 8-K 13 pages Amended and Restated Bylaws of Xenomics, Inc
12/34/56
EX-3.1
from 8-K 19 pages Articles of Amendment Designating Series a Convertible Preferred Stock of Xenomics, Inc. Pursuant to Section 607.0602 of the Florida Business Corporation Act
12/34/56
EX-3.(II).1
from 8-K ~20 pages Amended and Restated By-Laws
12/34/56
EX-3.(I).1
from 8-K 1 page Amended Articles of Incorporation
12/34/56